Alcon Canada Strengthens its Commitment to Astigmatic Patients with TOTAL30 for Astigmatism Expanded ParametersBusiness Wire • 02/27/25
Alcon Q4 Earnings Beat, Margins Rise, Stock Remains Stable in AfterhoursZacks Investment Research • 02/26/25
Alcon Reports Full-Year 2024 Results, with Strong Top-line and Earnings Growth and Record Cash GenerationBusiness Wire • 02/25/25
Alcon Announces U.S. Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Longest Lasting Formula YetBusiness Wire • 02/24/25
Wall Street's Insights Into Key Metrics Ahead of Alcon (ALC) Q4 EarningsZacks Investment Research • 02/20/25
Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular HypertensionBusiness Wire • 02/19/25
Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in AfterhoursZacks Investment Research • 11/13/24
Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash GenerationBusiness Wire • 11/12/24
What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 EarningsZacks Investment Research • 11/07/24
Innovation Aids Alcon Stock's Growth Despite Macroeconomic TroublesZacks Investment Research • 09/20/24